Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Weize, Fan"'
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Prourokinase is a single-chain plasminogen activator presenting with fewer hemorrhagic complications and reduced reocclusion rate compared with the conventional fibrinolytic agents in patients with coronary artery disease. However
Externí odkaz:
https://doaj.org/article/9651885e4cdc4e608c65c9626dad3ba7
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Prourokinase is a single-chain plasminogen activator presenting with fewer hemorrhagic complications and reduced reocclusion rate compared with the conventional fibrinolytic agents in patients with coronary artery disease. However, prourok
Publikováno v:
Experimental and Therapeutic Medicine
Acute coronary syndrome (ACS) is the main manifestation of cardiovascular disease and the primary cause of adult hospitalization in China. There is an urgent demand for novel biomarkers for the diagnosis of ACS. Although plasma cysteine-rich protein
Autor:
Yong‐Jun Li, Qing-Min Wei, Yunfa Jiang, Weize Fan, Yanming Fan, Guozhen Hao, Yang Fu, Xianghua Fu, Xinshun Gu
Publikováno v:
Catheterization and Cardiovascular Interventions
Objective To evaluate efficacy, safety and feasibility of targeted intracoronary injection using pro-urokinase combined with anisodamine (TCA) versus thrombus aspiration (TA) in ST-elevation myocardial infarction (STEMI) patients with high thrombus l
Autor:
Xinwei, Jia, Xianghua, Fu, Jing, Zhang, Xinshun, Gu, Ling, Xue, Weize, Fan, Guozhen, Hao, Yunfa, Jiang, Weili, Wu, Shiqiang, Li
Publikováno v:
In The American Journal of Cardiology 2009 104(4):519-524
Autor:
Qing Miao, Xinshun Gu, Wei Li, Shi-qiang Li, Xianghua Fu, Wei Geng, Weize Fan, Yunfa Jiang, Kun Xing, Guozhen Hao, Yanbo Wang
Publikováno v:
Heart and Vessels. 31:490-498
This study aims to investigate the effect of recombinant human brain natriuretic peptide (rhBNP) on renal function and contrast-induced nephropathy (CIN) incidence in ST-segment elevation myocardial infarction and heart failure (STEMI-HF) patients wi
Autor:
Shiqiang, Li, Xianghua, Fu, Yuhan, Dai, Chen, Liu, Yanbo, Wang, Wei, Li, Weili, Wu, Xinshun, Gu, Guozhen, Hao, Weize, Fan, Qing, Miao, Yunfa, Jiang
Publikováno v:
Zhonghua xin xue guan bing za zhi. 43(11)
To investigate whether the administration of recombinant human B-type natriuretic peptide (rhBNP) before primary percutaneous coronary intervention (PCI) could further limit the infract size, improve left ventricular function, and alleviate cardiac d
Autor:
Guozhen Hao, Wei Geng, Yunfa Jiang, Xiangnan Li, Zengxin Yang, Xianghua Fu, Wei Li, Xin-Shun Gu, Weize Fan, Shi-qiang Li, Weili Wu, Xuechao Wang, Yanbo Wang
Publikováno v:
Cardiology. 122:195-202
Objectives: To investigate whether preprocedural high-dose atorvastatin decreases the incidence of contrast-induced nephropathy (CIN) and protects the renal function after emergency percutaneous coronary intervention (PCI). Methods: Statin-naive pati
Publikováno v:
American journal of translational research. 8(1)
Objective: To investigate the effect of recombinant human brain natriuretic peptide (rhBNP) on renal function in patients with acute heart failure (AHF) following acute myocardial infarction (AMI). Methods: Consecutive patients with AHF following AMI
Autor:
Yunfa Jiang, Xinshun Gu, Xianghua Fu, Guozhen Hao, Qing Miao, Hong-Xiao Li, Weize Fan, Yanbo Wang, Qing Wang
Publikováno v:
Journal of the American College of Cardiology. 72:C167
To investigate the effects of levosimendan on right ventricular (RV) function in patients with acute decompensated heart failure (ADHF). Patients with ADHF admitted into our hospital from January 2017 to October 2017 were enrolled in this study, and